HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if pregnancy-limited, short-term combination HIV
treatment regimens -- which were used solely for the prevention of mother to child
transmission of HIV and discontinued postpartum -- decreases the effectiveness of a standard
initial regimen of anti-HIV drugs when subsequent treatment is needed.
Phase:
Phase 4
Details
Lead Sponsor:
AIDS Clinical Trials Group
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)
Treatments:
Efavirenz Emtricitabine Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination Tenofovir